| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
36,010,000 |
| Market
Cap: |
543.03(M) |
| Last
Volume: |
129,261 |
Avg
Vol: |
128,904 |
| 52
Week Range: |
$9.69 - $21.36 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Orthofix Medical is a medical device company. Co.'s Global Spine segment provides implantable medical devices, biologics, and other regenerative solutions. This segment's product categories include: Bone Growth Therapies, which manufactures, distributes, and provides support services for bone growth stimulation devices; Spinal Implants, which designs, develops and markets a portfolio of motion preservation and fixation implant products; and Biologics, which provides a portfolio of products and tissue forms. Co.'s Global Orthopedics segment provides products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,500 |
7,500 |
| Total Buy Value |
$0 |
$0 |
$101,025 |
$101,025 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
8,243 |
12,505 |
| Total Sell Value |
$0 |
$0 |
$156,617 |
$232,268 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
2 |
3 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Goodwin Robert Allen Ii |
President Biologics |
• – – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,198 |
22,257 |
|
- |
|
| Finegan Michael |
Chief Strategy Officer |
• – – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,857 |
32,794 |
|
- |
|
| Doug Rice |
CFO |
• – – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,693 |
34,870 |
|
- |
|
| Bianchi Davide |
President Extremity Fixation |
• – – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,528 |
51,972 |
|
- |
|
| Mason Brad |
CEO |
• • – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
18,551 |
147,572 |
|
- |
|
| Elting Kimberley A. |
Chief Legal Officer |
• – – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,407 |
12,790 |
|
- |
|
| Niemann Bradley V. |
President Biostim |
• – – |
2017-12-11 |
4 |
AS |
$52.08 |
$288,861 |
D/D |
(5,547) |
34,631 |
|
- |
|
| Mason Brad |
CEO |
• • – |
2017-11-28 |
4 |
S |
$53.48 |
$267,400 |
D/D |
(5,000) |
183,053 |
|
- |
|
| Faulstick Luke T |
Director |
– • – |
2017-11-06 |
4 |
S |
$51.22 |
$245,846 |
D/D |
(4,800) |
7,729 |
|
- |
|
| Bianchi Davide |
President Extremity Fixation |
• – – |
2017-09-12 |
4 |
D |
$49.72 |
$24,859 |
D/D |
(500) |
59,103 |
|
- |
|
| Niemann Bradley V. |
President Biostim |
• – – |
2017-09-11 |
4 |
AS |
$49.44 |
$343,926 |
D/D |
(6,956) |
40,178 |
|
- |
|
| Doug Rice |
CFO |
• – – |
2017-09-11 |
4 |
AS |
$49.46 |
$363,689 |
D/D |
(7,353) |
44,743 |
|
- |
|
| Goodwin Robert Allen Ii |
President Biologics |
• – – |
2017-08-24 |
4 |
D |
$48.29 |
$299,655 |
D/D |
(6,205) |
31,127 |
|
- |
|
| Mason Brad |
CEO |
• – – |
2017-08-21 |
4 |
S |
$48.10 |
$131,457 |
D/D |
(2,733) |
188,053 |
|
- |
|
| Fujikawa Raymond |
President Spine Fixation |
• – – |
2017-08-10 |
4 |
S |
$47.06 |
$299,502 |
D/D |
(6,364) |
31,084 |
|
- |
|
| Fujikawa Raymond |
President Spine Fixation |
• – – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,440 |
37,448 |
|
- |
|
| Elting Kimberley A. |
Chief Legal Officer |
• – – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,525 |
9,125 |
|
- |
|
| Niemann Bradley V. |
President Biostim |
• – – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,983 |
47,134 |
|
- |
|
| Goodwin Robert Allen Ii |
President Biologics |
• – – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,440 |
37,332 |
|
- |
|
| Bianchi Davide |
President Extremity Fixation |
• – – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,983 |
59,603 |
|
- |
|
| Finegan Michael |
Chief Strategy Officer |
• – – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,254 |
47,522 |
|
- |
|
| Mason Brad |
CEO |
• – – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
15,184 |
190,786 |
|
- |
|
| Doug Rice |
CFO |
• – – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,796 |
52,096 |
|
- |
|
| Faulstick Luke T |
Director |
– • – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,579 |
12,529 |
|
- |
|
| Marks Lilly |
Director |
– • – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,579 |
14,029 |
|
- |
|
697 Records found
|
|
Page 11 of 28 |
|
|
0.44 (3.01%) 
